1. Noronha-Blob L, Lowe VC, Peterson JS, Hanson RC. The anticholinergic activity of agents indicated for urinary incontinence is an important property for effective control do bladder dysfunction. J Pharmacol Exp Ther 1989;251:586-593.
2. Buyse G, Waldeck K, Verpoorten C, Bjork H, Casaer P, Andersson KE. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol 1998;160:892-896.
3. Schurch B, de Seze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005;174:196-200.
4. Ekstrom B, Andersson KE, Mattiason A. Urodynamic effects of intravesical instillation of atropine and phentolamine in patients with detrusor hyperactivity. J Urol 1993;149:155-158.
7. Kapural L, Mekhail N. Radiofrequency ablation for chronic pain control. Curr Pain Headache Rep 2001;5:517-525.
8. Mulcahy JJ, Young AB. Percutaneous radiofrequency sacral rhizotomy in the treatment of the hyperreflexic bladder. J Urol 1978;120:557-558.
9. Mulcahy JJ, Young AB. Long-term follow-up of percutaneous radiofrequency sacral rhizotomy. Urol 1990;35:76-77.
10. Weibing S, Dongwen W. Relationship between the bladder trabeculation grades and pressure of detrusor in benign prostatic hyperplasia. China J Mod Med 2010;20:723-725.
11. Arnold EP, Fukui J, Anthony A, Utley WL. Bladder function following spinal cord injury: a urodynamic analysis of the outcome. Br J Urol 1984;56:172-177.
12. Kim DY, Chancellor MB. Intravesical neuromodulatory drugs: capsaicin and resiniferatoxin to treat the overactive bladder. J Endourol 2000;14:97-103.
13. de Seze M, Wiart L, de Seze MP, Soyeur L, Dosque JP, Blajezewski S, Moore N, Brochet B, Mazaux JM, Barat M, et al. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study. J Urol 2004;171:251-255.
14. Shin JC, Park CI, Kim YW, Park SY, Rha DW, Kim JE. Stretching therapy of neurogenic bladder in patients with spinal cord injury. J Korean Acad Rehabil Med 2003;27:344-348.
15. Helmstein K. Treatment of bladder carcinoma by a hydrostatic pressure technique. Br J Urol 1972;44:434-450.
16. Dunn M, Ramsden PD, Roberts JB, Smith JC, Smith PJ. Interstitial cyctitis, treated by prolonged bladder distension. Br J Urol 1977;49:641-645.
17. Sluijter M, Racz G. Technical aspects of radiofrequency. Pain Pract 2002;2:195-200.
18. Blaivas JG. Pathophysiology of lower urinary tract dysfunction. Urol Clin North Am 1985;12:215-224.
19. Ferreira RS, Levi d'Ancona CA, Dantas-Filho VP, Rodrigues Netto, Miyaoka R. Percutaneous radiofrequency sacral rhizotomy in the treatment of neurogenic detrusor overactivity in spinal cord injured patients. Actas Urol Esp 2011;35:325-330.
20. Shin JC, Park CI, Kim YR, Bang IK, Kim JE. Clinical effectiveness of intravesical oxybutynin instillation in spinal cord injured patients with hyperreflexic or hypertonic neurogenic bladder. J Korean Acad Rehabil Med 2000;24:28-34.